ALGS Stock Analysis: Buy, Sell, or Hold?
ALGS - Aligos Therapeutics, Inc. Common Stock
$6.76
0.18 (2.81%)
▲
5d:
-7.14%
30d:
+28.03%
90d:
+26.12%
WAIT
LOW Confidence
Analysis Updated: Aug 18, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When ALGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALGS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALGS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALGS is currently trading at $6.76, which is considered extended relative to its 30-day fair value range of $4.48 to $6.60.
Technical Outlook: Technically, ALGS is in a downtrend. Immediate support is located at $4.18, while resistance sits at $7.82.
Market Sentiment: ALGS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $56.29 (+732.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALGS is in a downtrend. Immediate support is located at $4.18, while resistance sits at $7.82.
Market Sentiment: ALGS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $56.29 (+732.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.48 -
$6.60
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 732.6% below Wall St target ($56.29)
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.48 -
$6.60
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.18
Resistance Level
$7.82
Current Trend
Downtrend
Technical data as of
Aug 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.34
Wall Street Target
$56.29
(+732.6%)
Revenue Growth (YoY)
2778.5%
Profit Margin
-241.0%
Share & Embed Analysis
Last updated: August 19, 2026 7:40 AM ET
Data refreshes hourly during market hours. Next update: 8:40 AM
Data refreshes hourly during market hours. Next update: 8:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
